KLHL17 activators belong to a class of chemical compounds that target and modulate the activity of the KLHL17 protein, which is a member of the Kelch-like family characterized by a series of repeats that form a kelch motif. KLHL17, also known as kelch-like protein 17, is implicated in a variety of cellular processes due to its role in protein-protein interactions. These activators are designed to enhance the function of KLHL17, either by increasing its stability, promoting its interaction with other proteins, or facilitating its localization to specific cellular compartments where it exerts its action. The molecular intricacies of KLHL17 activation are complex, as the process may involve conformational changes in the protein structure that enhance its affinity for partner proteins or substrates, or perhaps the prevention of degradation pathways that would otherwise decrease KLHL17 levels.
The development and characterization of KLHL17 activators require a detailed understanding of the protein's structure and the molecular pathways it is involved in. The activators typically work by binding to the KLHL17 protein at specific sites that are critical for its function. These sites could be located in the kelch domain or other functional domains of the protein, which play a role in its ability to interact with other proteins and execute its functions. By binding to these sites, KLHL17 activators can induce conformational changes that either expose interaction sites or stabilize the protein in a configuration that is more conducive to function.
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | ¥2414.00 | ||
GSK-3β 的一种抑制剂,可通过阻止蛋白质泛素化和降解来稳定蛋白质,这可能会间接增加 KLHL17 的水平。 | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | ¥3159.00 | 4 | |
一种 DNA 甲基转移酶抑制因子,可导致基因的去甲基化和随后的转录,从而可能影响 KLHL17 的表达。 | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | ¥1681.00 ¥5303.00 ¥6995.00 ¥13527.00 ¥23579.00 | 33 | |
组蛋白去乙酰化酶抑制剂,可通过改变染色质结构增加基因表达,可能导致 KLHL17 合成增强。 | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | ¥790.00 ¥2234.00 | 18 | |
另一种GSK-3β抑制剂,可增加蛋白质稳定性,并可能提高KLHL17的水平或活性。 | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | ¥1489.00 ¥12004.00 | 115 | |
一种蛋白酶体抑制剂,用于阻止泛素化蛋白质的降解,可稳定 KLHL17。 | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | ¥857.00 ¥1692.00 ¥8179.00 ¥15626.00 ¥23128.00 | 73 | |
腺苷酸环化酶的激活剂,可提高细胞内 cAMP 水平,从而可能导致基因表达改变和 KLHL17 水平升高。 | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | ¥338.00 ¥519.00 ¥925.00 ¥2459.00 | 18 | |
组蛋白去乙酰化酶抑制剂,可增加组蛋白的乙酰化,从而使染色质结构更加松弛,并可能提高 KLHL17 的表达量。 | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | ¥2053.00 ¥7818.00 | 88 | |
一种 ROCK 抑制剂,可能会影响细胞骨架组织,并可能影响涉及 KLHL17 的细胞过程。 |